Postmenopausal HT doesn't improve--or impede--cognition


Not only shouldn't postmenopausal women take hormone therapy to prevent heart disease, they shouldn't use it to improve or protect cognitive function, according to a large population-based study.

Researchers included 1,462 postmenopausal women residing in Wisconsin and participating in the 5-year follow-up examination for the Epidemiology of Hearing Loss Study in 1998–2000. Ninety-four of the women were cognitively impaired as defined by low Mini-Mental State Examination scores, with 20% of the 94 receiving a diagnosis of Alzheimer's disease.

After adjusting for age, current HT users were slightly less likely than nonusers to be cognitively impaired, but the finding was not statistically significant. Similarly, neither current, past, nor duration of HT use was associated with cognitive impairment. Age and educational attainment seem to play more important roles in postmenopausal cognitive status.

Mitchell JL, Cruickshanks KJ, Klein BE, et al. Postmenopausal hormone therapy and its association with cognitive impairment. Arch Intern Med. 2003;163:2485-2490.

Related Videos
Exploring the intersection of heart health and women's health | Image Credit:
Unlocking the benefits of DHEA | Image Credit:
Unlocking the power of oxytocin | Image credit:
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit:
Deciding the best treatment for uterine fibroids | Image Credit:
Clinical pearls of pediatric dermatology | Image Credit:
Approaching inflammatory vulvovaginal diseases | Image Credit:
© 2024 MJH Life Sciences

All rights reserved.